Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Ulrich Petry

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
BMC Infectious Diseases|March 19, 2013
Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84--results of WOLVES, a population-based epidemiological study in Wolfsburg, GermanyKarl Ulrich Petry, Alexander Luyten, Annika Justus, et al.
International Journal of Cancer|February 13, 2014
Early detection of CIN3 and cervical cancer during long-term follow-up using HPV/Pap smear co-testing and risk-adapted follow-up in a locally organised screening programmeAlexander Luyten, Nina Buttmann-Schweiger, Katrin Luyten, et al.
GMS Health Technology Assessment|February 4, 2011
Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in GermanyGaby Sroczynski, Petra Schnell-Inderst, Nikolai Mühlberger, et al.
International Journal of Cancer|April 6, 2006
Overview of the European and North American studies on HPV testing in primary cervical cancer screeningJack Cuzick, Christine Clavel, Karl-Ulrich Petry, et al.
Vaccine|January 17, 2016
Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccinesPierre Van Damme, Paolo Bonanni, F Xavier Bosch, et al.
Journal of Lower Genital Tract Disease|May 7, 2013
Characterization of squamous cell cancers of the vulvar anterior fourchette by human papillomavirus, p16INK4a, and p53Miriam Reuschenbach, Judith Roos, Dimitrios Panayotopoulos, et al.
Journal of Medical Virology|May 8, 2008
Comparison of the performance of different HPV genotyping methods for detecting genital HPV typesStefanie J Klug, Anco Molijn, Betti Schopp, et al.
Obstetrics and Gynecology|February 3, 2004
ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trialFrancisco Garcia, Karl Ulrich Petry, Laila Muderspach, et al.
Journal of Lower Genital Tract Disease|August 5, 2014
Utility and Reproducibility of the International Federation for Cervical Pathology and Colposcopy Classification of Transformation Zones in Daily Practice: A Multicenter Study of the German Colposcopy NetworkAlexander Luyten, Nina Buttmann-Schweiger, Ingke Hagemann, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 15, 2015
Utility of EFC quality indicators for colposcopy in daily practice: results from an independent, prospective multicenter trialAlexander Luyten, Ingke Hagemann, Sarah Scherbring, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
BMC Infectious Diseases|March 19, 2013
Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84--results of WOLVES, a population-based epidemiological study in Wolfsburg, GermanyKarl Ulrich Petry, Alexander Luyten, Annika Justus, et al.
International Journal of Cancer|February 13, 2014
Early detection of CIN3 and cervical cancer during long-term follow-up using HPV/Pap smear co-testing and risk-adapted follow-up in a locally organised screening programmeAlexander Luyten, Nina Buttmann-Schweiger, Katrin Luyten, et al.
GMS Health Technology Assessment|February 4, 2011
Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in GermanyGaby Sroczynski, Petra Schnell-Inderst, Nikolai Mühlberger, et al.
International Journal of Cancer|April 6, 2006
Overview of the European and North American studies on HPV testing in primary cervical cancer screeningJack Cuzick, Christine Clavel, Karl-Ulrich Petry, et al.
Vaccine|January 17, 2016
Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccinesPierre Van Damme, Paolo Bonanni, F Xavier Bosch, et al.
Journal of Lower Genital Tract Disease|May 7, 2013
Characterization of squamous cell cancers of the vulvar anterior fourchette by human papillomavirus, p16INK4a, and p53Miriam Reuschenbach, Judith Roos, Dimitrios Panayotopoulos, et al.
Journal of Medical Virology|May 8, 2008
Comparison of the performance of different HPV genotyping methods for detecting genital HPV typesStefanie J Klug, Anco Molijn, Betti Schopp, et al.
Obstetrics and Gynecology|February 3, 2004
ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trialFrancisco Garcia, Karl Ulrich Petry, Laila Muderspach, et al.
Journal of Lower Genital Tract Disease|August 5, 2014
Utility and Reproducibility of the International Federation for Cervical Pathology and Colposcopy Classification of Transformation Zones in Daily Practice: A Multicenter Study of the German Colposcopy NetworkAlexander Luyten, Nina Buttmann-Schweiger, Ingke Hagemann, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 15, 2015
Utility of EFC quality indicators for colposcopy in daily practice: results from an independent, prospective multicenter trialAlexander Luyten, Ingke Hagemann, Sarah Scherbring, et al.
Pageof 5